Clinical trials have demonstrated that patients using tirzepatide can achieve significant weight reduction, with some studies reporting average weight loss of up to 20% of body weight
In people with type 2 diabetes, the risk is modestly higher, yet it is still uncommon on an annual basis
Moving on to the SELECT trial , one substudy demonstrated semaglutide to be more effective in women for reducing inflammation and body mass
Clean office, friendly staff, and a provider who actually listens
Furthermore, GLP-1RA is related to decreased body weight, which is unfavorable for bone fractures as weight loss induces mechanical loading and bone mass decrease
The condition, known as peripheral neuropathy, can cause permanent nerve damage